Acute tumor lysis syndrome triggered by zoledronic acid in a patient with metastatic lung adenocarcinoma

Kurt M., Onal I., Elkiran T., Altun B., Altundag K., Gullu I.

MEDICAL ONCOLOGY, cilt.22, sa.2, ss.203-206, 2005 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Editöre Mektup
  • Cilt numarası: 22 Sayı: 2
  • Basım Tarihi: 2005
  • Doi Numarası: 10.1385/mo:22:2:203
  • Dergi Adı: MEDICAL ONCOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.203-206
  • Hacettepe Üniversitesi Adresli: Evet

Özet

We report the case of a 52-yr-old man with metastatic lung adenocarcinoma who developed tumor lysis syndrome after administration of zoledronic acid. Tumor lysis syndrome in solid tumors and the antitumor effect of the zolendronic acid are discussed in light of the pertinent literature.